Cited by 527Allergic Rhinitis and SensitizationAsthma and respiratory diseasesSinusitis and nasal conditions

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

Open access
Weiner, John M, Abramson, Michael J, Puy, Robert M·1998·BMJ

Abstract

Objective: To determine whether intranasal corticosteroids are superior to oral H 1 receptor antagonists (antihistamines) in the treatment of allergic rhinitis. Design: Meta-analysis of randomised controlled trials comparing intranasal corticosteroids with oral antihistamines. Setting: Randomised controlled trials conducted worldwide and published between 1966 and 1997. Subjects: 2267 subjects with allergic rhinitis in 16 randomised controlled trials. Main outcome measures: Nasal blockage, nasal discharge, sneezing, nasal itch, postnasal drip, nasal discomfort, total nasal symptoms, nasal resistance, and eye symptoms and global ratings. Outcomes measured on different scales were combined to determine pooled odds ratios (categorical outcomes) or standardised mean differences (continuous outcomes). Assessment of heterogeneity between studies, and subgroup analyses of eye symptoms, were undertaken. Results: Intranasal corticosteroids produced significantly greater relief than oral antihistamines of nasal blockage (standardised mean difference −0.63, 95% confidence interval −0.73 to −0.53), nasal discharge (−0.5, −0.6 to −0.4), sneezing (−0.49, −0.59 to −0.39), nasal itch (−0.38, −0.49 to −0.21), postnasal drip (−0.24, −0.42 to −0.06), and total nasal symptoms (−0.42, −0.53 to −0.32), and global ratings gave an odds ratio for deterioration of symptoms of 0.26 (0.08 to 0.8). There were no significant differences between treatments for nasal discomfort, nasal resistance, or eye symptoms. The effects on sneezing, total nasal symptoms, and eye symptoms were significantly heterogeneous between studies. Other combined outcomes were homogeneous between studies. Subgroup analysis of the outcome of eye symptoms suggested that the duration of assessment (averaged mean score over the study period versus mean score at end of study period) might have accounted for the heterogeneity. Conclusion: The results of this systematic review, together with data on safety and cost effectiveness, support the use of intranasal corticosteroids over oral antihistamines as first line treatment for allergic rhinitis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.317.7173.1624

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A meta-analysis by Weiner et al. found that intranasal corticosteroids were more effective than oral antihistamines at treating nasal blockage, although there were no significant differences between treatments on nasal resistance.

    “A meta-analysis by Weiner et al.1297 found that INCSs were more effective than oral antihistamines at treating nasal blockage, although there was no significant differences between treatments on nasal resistance.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. Hopper T, Jenkin M, Carlin C, Giles G. Increase in the self-reported prevalence of asthma and hay fever in adults over the past generation. Aust J Pub Health 1995;19:120-4.
  2. Calderon-Zapata MA, Davies RJ. Treatment and management of allergic rhinitis. In: Kay AB, ed. Allergy and allergic diseases. Oxford: Blackwell, 1997.
  3. Prenner BM. Allergies for all seasons! Allergy Asthma 1997;6:8-9.
  4. Ramsdale EH, Kline PA. Comparison of an intranasal steroid (budesonide) with terfenadine in the treatment of ragweed-induced rhinoconjunctivitis. J Allergy Clin Immunol 1990;85:244. [Abstract.]
  5. Stricker W, Klimas J, Mendelson L, Morris RJ, Reed CE, Shapiro G, et al. Intranasal fluticasone propionate is more effective than astemizole for seasonal allergic rhinitis. Ann Allergy 1994;72:86. [Abstract.]
  6. Berka C, Chin W. Fluticasone propionate intranasal steroid: cost- effectiveness vs antihistamines. J Allergy Clin Immunol 1994;93:165. [Abstract.]

Cited by

Sorted by citations

Authors
Weiner, J. M., Abramson, M. J., & Puy, R. M.
Affiliations
  • Monash University (AU)
  • The Alfred Hospital (AU)
Corresponding author
Weiner, John M
Venue
BMJ
Publisher
BMJ
Published
1998-12-12
Volume
317
Issue
7173
Pages
1624-1629
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2001450061
Cited by
527
References
55
Citations by year
2026: 6 · 2025: 3 · 2024: 12 · 2023: 16 · 2022: 8 · 2021: 6 · 2020: 14 · 2019: 14 · 2018: 9 · 2017: 13 · 2016: 24 · 2015: 14 · 2014: 17 · 2013: 15 · 2012: 18
FWCI
2.01
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Wellcome Trust
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
Keywords
allergic rhinitis, intranasal corticosteroids, oral antihistamines, histamine H1 receptor antagonists, nasal obstruction, rhinorrhea, sneezing, postnasal drip, ocular symptoms, treatment efficacy comparison, first-line therapy, symptom heterogeneity, nasal resistance, cost-effectiveness
MeSH terms
Administration, Intranasal, Administration, Oral, Adrenal Cortex Hormones, Female, Humans, Male, Receptors, Histamine H1, Rhinitis, Allergic, Perennial, Randomized Controlled Trials as Topic, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review